Can I read Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement on EtoBox?

Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement by George A. Mensah MD FACC & Natalie Arnold MD & Sumanth D. Prabhu MD FACC & Paul M Ridker MD MPH FACC & Francine K. Welty MD PhD FACC is a nonfiction available to read on EtoBox.

What is Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement about?

Journal of the American College of Cardiology, Corrected proof. doi:10.1016/j.jacc.2025.08.047ABSTRACTThe crucial role of inflammation in the pathogenesis and clinical outcomes of cardiovascular disease (CVD) has recently gained increased attention. In particular, residual inflammation, measured with high-sensitivity C-reactive protein (hsCRP) remains strongly predictive of recurrent events, even in statin-treated patients. Similarly, elevated hsCRP in apparently healthy individuals identifies a higher-risk group in whom statin therapy significantly reduces the risk of first major CVD events even if LDL-cholesterol is normal. This report provides an updated understanding of the role of chronic, low-grade inflammation in CVD and highlights new seminal research findings, especially in atherosclerosis, myocardial infarction, heart failure, and pericarditis. Consensus recommendations are summarized for screening, evaluation, and CVD risk assessment; inflammatory biomarkers in cardiovascular imaging; inflammation inhibition in behavioral and lifestyle risks; and antiinflammatory approaches in primary and secondary prevention as well as in heart failure and other CVDs. This report also

Who reads Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement?

Author

George A. Mensah MD FACC & Natalie Arnold MD & Sumanth D. Prabhu MD FACC & Paul M Ridker MD MPH FACC & Francine K. Welty MD PhD FACC

Publisher

X(The American College of Cardiology Foundation)

Published

2025

Language

EN

Category

nonfiction

Subjects

Medical, Cardiology, Medicine